Related Experiment Videos
Current therapy for malignant mesothelioma
1Multidisciplinary Mesothelioma Thoracic Oncology Program, Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 445, Houston, USA. rsmythe@mail.mdanderson.org
Abstract:
This review briefly summarizes the results of previous systemic (chemotherapy) and local (surgery and radiotherapy) treatment attempted to date for malignant mesothelioma. The prospects for newer modalities, ie molecular and biologic therapies, are also highlighted, including results of both preclinical and early clinical research.
Insights
This review covers current treatments for malignant mesothelioma, including chemotherapy, surgery, and radiotherapy. It also explores promising new molecular and biologic therapies based on preclinical and early clinical research.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Oncology
Background:
- Malignant mesothelioma is an aggressive cancer with limited treatment options.
- Systemic and local therapies have shown varying efficacy in managing this disease.
Purpose of the Study:
- To review existing treatment modalities for malignant mesothelioma.
- To highlight the potential of novel molecular and biologic therapies.
Main Methods:
- Literature review of systemic treatments (chemotherapy).
- Literature review of local treatments (surgery, radiotherapy).
- Summary of preclinical and early clinical research on new therapies.
Main Results:
- Past treatments like chemotherapy, surgery, and radiotherapy have been evaluated.
- Emerging molecular and biologic therapies show potential in early-stage research.
Conclusions:
- Current treatment strategies for malignant mesothelioma are discussed.
- Future therapeutic avenues involving targeted and immune-based therapies are promising.